Insider · CIK 0001771213
Rekha Hemrajani
Files at MXCT (MAXCYTE, INC.), LBRX (LB PHARMACEUTICALS INC), BIOA (BioAge Labs, Inc.), ALXO (ALX ONCOLOGY HOLDINGS INC). First filing Dec 4, 2024, latest Aug 27, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
MXCT: MAXCYTE, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
ALXO: ALX ONCOLOGY HOLDINGS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | MAXCYTE, INC. | $22k 10,684 shares | -21% | +9% from low-56% from high | |
| 31Weak | ALXObuy ALX ONCOLOGY HOLDINGS INC | $46k 30,000 shares | +1000% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +22,449 | $0.00 | $0 | 22,449 | Sep 12, 2025 |
| Jun 25, 2025 | MXCT MAXCYTE, INC. | SOpen-market sale Common Stock10b5-1 | -10,684 | $2.09 | $22k | 39,893 | Aug 27, 2025 |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | AGrant or award Common Stock | +29,210 | $0.00 | $0 | 50,577 | Jun 23, 2025 |
| Jun 18, 2025 | MXCT MAXCYTE, INC. | AGrant or award Stock Option (right to buy)derivative | +50,790 | $0.00 | $0 | 50,790 | Jun 23, 2025 |
| Jun 5, 2025 | BIOA BioAge Labs, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,000 | $0.00 | $0 | 22,000 | Jun 9, 2025 |
| Jan 21, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Stock Option (right to buy)derivative | +40,400 | $0.00 | $0 | 40,400 | Jan 23, 2025 |
| Dec 2, 2024 | ALXO ALX ONCOLOGY HOLDINGS INC | POpen-market purchase Common Stock | +30,000 | $1.55 | $46k | 33,000 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.